SENSEX
NIFTY
GOLD
USD/INR

Weather

image 20    C

Economy News

The Economic Times

Economy / The Economic Times

details

AstraZeneca India plans to sell 64-acre Bengaluru site for Rs 3,400 crore

The land parcel, expected to fetch about 3,400 crore for AstraZeneca Pharma India, has drawn interest from developers including the Sattva Group, Aurobindo Pharma and RMZ. The company is looking to sell it as part of a broader land monetisation strategy.

10 Apr 2026 1:11 am